BWM
AIMT

BerganKDV Wealth Management’s Aimmune Therapeutics AIMT Stock Holding History

BerganKDV Wealth Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed – – 1035
2020
Q3 		$0 Sell
4
-41
-91% -$873 ﹤0.01% 1040
2020
Q2 		$1K Hold
45
– – ﹤0.01% 939
2020
Q1 		$1K Hold
45
– – ﹤0.01% 911
2019
Q4 		$2K Hold
45
– – ﹤0.01% 812
2019
Q3 		$1K Buy
+45
New +$919 ﹤0.01% 685

BerganKDV Wealth Management's AIMT Position: Q4 2020 in Review

BerganKDV Wealth Management sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 4 shares.

BerganKDV Wealth Management first reported a position in AIMT in Q3 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • BerganKDV Wealth Management reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • BerganKDV Wealth Management sold 4 Aimmune Therapeutics shares in Q4 2020.
  • BerganKDV Wealth Management first reported a position in Aimmune Therapeutics in Q3 2019 and held it in 5 quarters.
  • BerganKDV Wealth Management's Aimmune Therapeutics position peaked at $2K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on BerganKDV Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.